These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1642288)

  • 21. Evidence for genetic heterogeneity in X-linked familial exudative vitreoretinopathy.
    Shastry BS; Liu X; Hejtmancik JF; Plager DA; Trese MT
    Genomics; 1997 Sep; 44(2):247-8. PubMed ID: 9299244
    [No Abstract]   [Full Text] [Related]  

  • 22. Linkage and candidate gene analysis of X-linked familial exudative vitreoretinopathy.
    Shastry BS; Hejtmancik JF; Plager DA; Hartzer MK; Trese MT
    Genomics; 1995 May; 27(2):341-4. PubMed ID: 7558002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial exudative vitreoretinopathy.
    Ebert EM; Mukai S
    Int Ophthalmol Clin; 1993; 33(2):237-47. PubMed ID: 8325737
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel and recurrent NDP gene mutations in familial cases of Norrie disease and X-linked exudative vitreoretinopathy.
    Pelcastre EL; Villanueva-Mendoza C; Zenteno JC
    Clin Exp Ophthalmol; 2010 May; 38(4):367-74. PubMed ID: 20491809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential diagnosis of leukokoria in children.
    François J
    Ann Ophthalmol; 1978 Oct; 10(10):1375-8, 1381-2. PubMed ID: 568907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy.
    Boonstra FN; van Nouhuys CE; Schuil J; de Wijs IJ; van der Donk KP; Nikopoulos K; Mukhopadhyay A; Scheffer H; Tilanus MA; Cremers FP; Hoefsloot LH
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4379-85. PubMed ID: 19324841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial exudative vitreoretinopathy.
    Bergen RL; Glassman R
    Ann Ophthalmol; 1983 Mar; 15(3):275-6. PubMed ID: 6847052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial exudative vitreoretinopathy.
    Tasman W; Augsburger JJ; Shields JA; Caputo A; Annesley WH
    Trans Am Ophthalmol Soc; 1981; 79():211-26. PubMed ID: 7342402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant exudative vitreoretinopathy.
    van Nouhuys CE
    Ophthalmic Paediatr Genet; 1985 Feb; 5(1-2):31-8. PubMed ID: 4058870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial exudative vitreoretinopathy associated with monocular axial myopia.
    Cheeseman EW; Bressler NM; Hunter DG
    Retina; 1999; 19(3):257-9. PubMed ID: 10380037
    [No Abstract]   [Full Text] [Related]  

  • 31. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy.
    Chen ZY; Battinelli EM; Fielder A; Bundey S; Sims K; Breakefield XO; Craig IW
    Nat Genet; 1993 Oct; 5(2):180-3. PubMed ID: 8252044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymmetry of familial exudative vitreoretinopathy.
    Shukla SY; Kaliki S; Shields CL
    J Pediatr Ophthalmol Strabismus; 2012 Feb; 49 Online():e5-8. PubMed ID: 22372757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Criswick-Schepens syndrome -- familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].
    Alsheikheh A; Lieb W; Grehn F
    Ophthalmologe; 2004 Sep; 101(9):914-8. PubMed ID: 15067562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norrie disease and exudative vitreoretinopathy in families with affected female carriers.
    Shastry BS; Hiraoka M; Trese DC; Trese MT
    Eur J Ophthalmol; 1999; 9(3):238-42. PubMed ID: 10544980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrolental white mass.
    Buyck A; Casteels I; Dralands L; Missotten L
    Bull Soc Belge Ophtalmol; 1991; 241():61-68. PubMed ID: 1840997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral retinal vascular hypoplasia associated with persistence of the primary vitreous: a new clinical entity?
    Sneed PJ; Augsburger JJ; Shields JA; Tasman W; Addiego R
    J Pediatr Ophthalmol Strabismus; 1988; 25(2):77-85. PubMed ID: 3282058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved surgical treatment of familial exudative vitreoretinopathy in children.
    Glazer LC; Maguire A; Blumenkranz MS; Trese MT; Green WR
    Am J Ophthalmol; 1995 Oct; 120(4):471-9. PubMed ID: 7573305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.
    Toomes C; Downey LM; Bottomley HM; Mintz-Hittner HA; Inglehearn CF
    Br J Ophthalmol; 2005 Feb; 89(2):194-7. PubMed ID: 15665352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation of familial exudative vitreoretinopathy.
    Ranchod TM; Ho LY; Drenser KA; Capone A; Trese MT
    Ophthalmology; 2011 Oct; 118(10):2070-5. PubMed ID: 21868098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Criswick-Schepens syndrome (familial exudative vitreoretinopathy). Study of a Colombian kindred.
    Nicholson DH; Galvis V
    Arch Ophthalmol; 1984 Oct; 102(10):1519-22. PubMed ID: 6487118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.